Eszopiclone
Product Name : Eszopiclone
Grade : IP / BP / USP
Therapeutic Category : Hypnotic
CAS No : 138729-47-2
COA : Available
MSDS : Available
Description
Eszopiclone is slightly effective in the treatment of insomnia where difficulty in falling asleep is the primary complaint.
- Appearance: White or almost slightly powder (Results:Complies)
- Identification: Positive(Results:Complies)
- R-Enantiomer: ≤0.5% (Results:0.04%)
- Individual impurity :≤0.3%(Results:0.04%)
- Total impurities: ≤0.5%(Results:0.05%)
- Residue on ignition: ≤0.2%(Results:0.06%)
- Heavy Metal: ≤10ppm(Results:Complies)
- Specific rotation: +125°~+141°(Results:+138°)
- Loss on drying: ≥98.5%(Results:99.60%)
- Conclusion: Meets the Requirements
Packaging details:
Packaging details: 25kg/drum with double plastic bags inside; packed in a cardboard drum or fiber HDPE drum.
Storage: Stored in a clean, cool, dry area; keep away from moisture and strong, direct light/heat.
Shelf Life: 5 years if sealed and store away from direct sun light.
Additional Information
The most widely recognized markets for this item incorporate the accompanying nations. If you don’t mind ask with us if your nation or district isn’t recorded:
ASIA: Saudi Arabia, Singapore, Syria, Philippines, Turkey, Turkmenistan, Afghanistan, Israel, Jordan, Pakistan, Russia, Uzbekistan, Yemen, Vietnam, Indonesia, Malaysia, Iran, Tajikistan, and so forth..
AFRICA: South Africa, Uganda, Ethiopia, Libya, Sudan, Congo, Gambia, Ivory Coast, Nigeria, Ghana, Kenya, Mauritius, Botswana, Egypt, and so forth.
NORTH & SOUTH AMERICA: Dominican Republic, Argentina, Guatemala, Guyana, Peru, Bolivia, Venezuela, USA, Canada, Panama, Trinidad and Tobago, Costa Rica, Puerto Rico, Brazil, Bahamas, Ecuador, and so forth .
EUROPE: France, Georgia, Germany, Hungary, Ireland, Iceland, Netherlands, Norway, Austria, Azerbaijan, Belarus, Belgium, Cyprus, Czech Republic, Denmark, Poland, Spain, Sweden, Switzerland, Ukraine, United Kingdom (UK) , Latvia, and so forth.
OCEANIA: Fiji, Australia, New Zealand, and so forth.
© Chemconpharma | Created By by TechRhombus